Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients

Clinical Infectious Diseases

Volumn 57, Issue 3, 2013, Pages 407-414

  Kundu, Samit ^a   Lockwood, Julianne ^b   Depledge, Daniel P ^a   Chaudhry, Yasmin ^c   Aston, Antony ^d   Rao, Kanchan ^b   Hartley, John C ^b   Goodfellow, Ian ^c   Breuer, Judith ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Next generation sequencing; Norovirus; Nosocomial transmission; Whole genome

Indexed keywords

COMPLEMENTARY DNA; CYCLOSPORIN A; INFLIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; CONSENSUS SEQUENCE; CROSS INFECTION; FECES ANALYSIS; FEMALE; GENE SEQUENCE; GENOTYPE; HEMOPHAGOCYTIC SYNDROME; HUMAN; INFANT; INFECTION CONTROL; IPEX SYNDROME; MALE; NONHUMAN; NOROVIRUS; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEVERE COMBINED IMMUNODEFICIENCY; VIRUS GENOME; VIRUS TRANSMISSION;

NEXT-GENERATION SEQUENCING; NOROVIRUS; NOSOCOMIAL TRANSMISSION; WHOLE GENOME;

CALICIVIRIDAE INFECTIONS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CROSS INFECTION; FEMALE; GASTROENTERITIS; GENOME, VIRAL; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFANT; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; NOROVIRUS; PHYLOGENY; RNA, VIRAL;

EID: 84880377433     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit287     Document Type: Article

References (40)

1. Tam CC, Rodrigues LC, Viviani L, et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 2012; 61:69-77.
2. Lopman B, Vennema H, Kohli E, et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 2004; 363:682-8.
3. Green KY, Belliot G, Taylor JL, et al. A predominant role for Norwalklike viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J Infect Dis 2002; 185:133-46.
4. Billgren M, Christenson B, Hedlund K-O, Vinjé J. Epidemiology of Norwalk-like human caliciviruses in hospital outbreaks of acute gastroenteritis in the Stockholm area in 1996. J Infect 2002; 44:26-32.
5. Sukhrie FH, Beersma MFC, Wong A, et al. Using molecular epidemiology to trace transmission of nosocomial norovirus infection. J Clin Microbiol 2011; 49:602-6.
6. Illingworth E, Taborn E, Fielding D, Cheesbrough J, Diggle PJ, Orr D. Is closure of entire wards necessary to control norovirus outbreaks in hospital? Comparing the effectiveness of two infection control strategies. J Hosp Infect 2011; 79:32-7.
7. Teunis PFM, Moe CL, Liu P, et al. Norwalk virus: how infectious is it? J Med Virol 2008; 80:1468-76.
8. Richards GP, Watson MA, Meade GK, Hovan GL, Kingsley DH. Resilience of norovirus GII.4 to freezing and thawing: implications for virus infectivity. Food and Environmental Virology 2012; 4:192-7.
9. Kim SJ, Si J, Lee JE, Ko G. Temperature and humidity influences on inactivation kinetics of enteric viruses on surfaces. Environ Sci Technol 2012; 46:13303-10.
10. Ludwig A, Adams O, Laws H-J, Schroten H, Tenenbaum T. Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus. J Med Virol 2008; 80:1461-7.
11. Cao S, Lou Z, Tan M, et al. Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol 2007; 81:5949-57.
12. Chen R, Neill JD, Estes MK, Prasad BVV. X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A 2006; 103:8048-53.
13. Lochridge VP, Jutila KL, Graff JW, Hardy ME. Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions. J Gen Virol 2005; 86:2799-806.
14. Thorne L, Bailey D, Goodfellow I. High-resolution functional profiling of the norovirus genome. J Virol 2012; 86:11441-56.
15. Siebenga JJ, Vennema H, Zheng D-P, et al. Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis 2009; 200:802-12.
16. Zheng D-P, Widdowson M-A, Glass RI, Vinjé J. Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J Clin Microbiol 2010; 48:168-77.
17. Kageyama T, Kojima S, Shinohara M, et al. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J Clin Microbiol 2003; 41:1548-57.
18. Stals A, Baert L, Botteldoorn N, et al. Multiplex real-time RT-PCR for simultaneous detection of GI/GII noroviruses and murine norovirus 1. J Virol Methods 2009; 161:247-53.
19. Bok K, Abente EJ, Realpe-Quintero M, et al. Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol 2009; 83:11890-901.
20. Delcher AL, Phillippy A, Carlton J, Salzberg SL. Fast algorithms for large-scale genome alignment and comparison. Nucleic Acids Res 2002; 30:2478-83.
21. Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25:2078-9.
22. Katoh K. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 2002; 30: 3059-66.
23. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 2012; 29:1969-73.
24. Posada D. jModelTest: phylogenetic model averaging. Mol Biol Evol 2008; 25:1253-6.
25. Bull RA, Eden J-S, Luciani F, McElroy K, Rawlinson WD, White PA. Contribution of intra- and interhost dynamics to norovirus evolution. J Virol 2012; 86:3219-29.
26. Koboldt DC, Zhang Q, Larson DE, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 2012; 22:568-76.
27. Kroneman A, Vennema H, Harris J, et al. Increase in norovirus activity reported in Europe. Euro Surveill 2006; 11:E061214.1.
28. Yen C, Wikswo ME, Lopman BA, Vinje J, Parashar UD, Hall AJ. Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States. Clin Infect Dis 2011; 53:568-71.
29. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinjé J. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg Infect Dis 2011; 17:1389-95.
30. Mathijs E, Stals A, Baert L, et al. A review of known and hypothetical transmission routes for noroviruses. Food Environ Virol 2012; 4:131-52.
31. Siebenga JJ, Vennema H, Renckens B, et al. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol 2007; 81:9932-41.
32. Lindesmith LC, Donaldson EF, Baric RS. Norovirus GII.4 strain antigenic variation. J Virol 2011; 85:231-42.
33. Lindesmith LC, Donaldson EF, Lobue AD, et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 2008; 5:e31.
34. Tan M, Huang P, Meller J, Zhong W, Farkas T, Jiang X. Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol 2003; 77:12562-71.
35. Lindesmith LC, Beltramello M, Donaldson EF, et al. Immunogenetic mechanisms driving norovirus GII .4 antigenic variation. PLoS Pathog 2012; 8:1-18.
36. Debbink K, Donaldson EF, Lindesmith LC, Baric RS. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J Virol 2012; 86:1214-26.
37. Allen DJ, Gray JJ, Gallimore CI, et al. Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes. PLoS One 2008; 3:1-9.
38. Schorn R, Höhne M, Meerbach A, et al. Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution. Clin Infect Dis 2010; 51:307-14.
39. Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012; 367:2126-32.
40. Verhoef L, Williams KP, Kroneman A, Sobral B, Van Pelt W, Koopmans M. Selection of a phylogenetically informative region of the norovirus genome for outbreak linkage. Virus Genes 2012; 44: 8-18.